BOCA RATON, Fla. – ADT’s refocus on its core consumer security and smart home business has paid off, with a strong start to 2024, company officials said. The company reported total revenue of $1.2 ...
Home security giant ADT has confirmed a data breach after the ShinyHunters extortion group threatened to leak stolen data unless a ransom is paid. In a statement shared today, the company said it ...
UPDATE 4/27: The breach notification service Have I Been Pwned received a sample of the stolen data, which indicates 5.5 million user email addresses were affected. Home security provider ADT has ...
CEO James DeVries highlighted that "ADT again delivered a solid quarter and that our overall performance for 2025 was within the guidance ranges we shared at the beginning of the year and updated on ...
Shares of ADT were lower after the company logged lower a fourth-quarter profit and said it expects profit and revenue to be flat for the year. The stock slipped 5.4%, to $7.59, in premarket trading ...
Tyler has worked on, lived with and tested all types of smart home and security technology for over a dozen years, explaining the latest features, privacy tricks, and top recommendations. With degrees ...
The company will use Origin Wireless’ AI sensing to expand the capabilities of its smart home security products. The company will use Origin Wireless’ AI sensing to expand the capabilities of its ...
BOCA RATON, Fla., Feb. 24, 2026 (GLOBE NEWSWIRE) -- ADT Inc. (NYSE: ADT), a leading provider of security, interactive, and smart home solutions serving residential and small business customers in the ...
All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. Tired of losing power in a ...
Patients who received ADT for 3 months or 9 months had worse overall survival than those treated for 36 months. For men with prostate cancer treated with definitive radiotherapy, the benefit derived ...
Androgen deprivation therapy (ADT), also called hormone therapy, is a common treatment for metastatic prostate cancer. It works by starving the cancer of testosterone, which fuels the tumor’s growth.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results